English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  DetailsSummary

Released
Journal Article

Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: A randomized, placebo-controlled, double-blind and crossover trial

MPS-Authors
/persons/resource/persons141337

Preckel,  Katrin
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19764

Kanske,  Philipp
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons20000

Singer,  Tania
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Preckel_Kanske_2016.pdf
(Publisher version), 699KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Preckel, K., Kanske, P., Singer, T., Paulus, F. M., & Krach, S. (2016). Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: A randomized, placebo-controlled, double-blind and crossover trial. BMC Psychiatry, 16: 329. doi:10.1186/s12888-016-1036-x.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-4FE8-2
Abstract
Autism spectrum disorders are neurodevelopmental conditions with severe impairments in social communication and interaction. Pioneering research suggests that oxytocin can improve motivation, cognition and attention to social cues in patients with autism spectrum disorder. The aim of this clinical trial is to characterize basic mechanisms of action of acute oxytocin treatment on neural levels and to relate these to changes in different levels of socio-affective and -cognitive functioning.